日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Results from the 32-week, phase 3 DISCREET study of apremilast in patients with moderate to severe genital psoriasis

一项为期 32 周的 3 期 DISCREET 研究结果显示，阿普米司特可有效治疗中重度生殖器银屑病患者。

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.70110
Merola, Joseph F; Guenther, Lyn; Lynde, Charles; Papp, Kim A; Parish, Lawrence Charles; Yamauchi, Paul; Cheng, Sue; Amouzadeh, Hamid; Deignan, Cynthia; Jardon, Shauna; Chen, Mindy; Pinter, Andreas
银屑病
发表日期：2026
文献求助 收藏

Safety and efficacy of nemolizumab for atopic dermatitis up to 2 years in open-label extension study

一项开放标签扩展研究评估了nemolizumab治疗特应性皮炎长达2年的安全性和有效性

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.70080
Augustin, Matthias; Tauber, Marie; Sidbury, Robert; Silverberg, Jonathan I; Papp, Kim A; Thaçi, Diamant; De Bruin-Weller, Marjolein S; Reich, Adam; Peris, Ketty; Barber, Kirk; Galus, Ryszard; Kaszuba, Andrzej; Zirwas, Matthew; Nahm, Walter K; Trullenque, Gretel; Maintz, Laura; Alpizar, Sady; Son, Sang Wook; Laquer, Vivian; Gold, Linda Stein; Cheong, Soo Yeon; Ryzhkova, Anna; Drahos, Agnes; Ulianov, Liliana; Piketty, Christophe
发表日期：2026
文献求助 收藏

Efficacy and safety of ME3183, an oral phosphodiesterase 4 inhibitor, in patients with plaque psoriasis

口服磷酸二酯酶4抑制剂ME3183治疗斑块状银屑病患者的疗效和安全性

期刊:Journal of the European Academy of Dermatology and Venereology
影响因子:8
doi:10.1111/jdv.20863
Papp, Kim A; Armstrong, April W; Koresawa, Tomokazu; Otake, Kazunari; Hirata, Masayuki; Kano, Akiko
银屑病
发表日期：2026
文献求助 收藏

Bimekizumab Impact on Patient-Reported Outcomes in Plaque Psoriasis: 4-Year Results from BE SURE, BE VIVID, BE READY, and BE BRIGHT

比美珠单抗对斑块状银屑病患者报告结局的影响：来自 BE SURE、BE VIVID、BE READY 和 BE BRIGHT 研究的 4 年结果

期刊:Dermatology and Therapy
影响因子:4.2
doi:10.1007/s13555-025-01595-9
Armstrong, April; Papp, Kim A; Lebwohl, Mark; Savage, Laura J; Yamanaka, Keiichi; Vlase, Diana Elena; Warham, Rhys; Lambert, Jérémy; López Pinto, José M; Wixted, Krista; Thaçi, Diamant
银屑病
发表日期：2026
文献求助 收藏

Safety and Efficacy of Deucravacitinib in Moderate to Severe Plaque Psoriasis for Up to 3 Years: An Open-Label Extension of Randomized Clinical Trials

Deucravacitinib治疗中重度斑块状银屑病长达3年的安全性和有效性：一项随机临床试验的开放标签扩展研究

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2024.4688
Armstrong, April W; Lebwohl, Mark; Warren, Richard B; Sofen, Howard; Imafuku, Shinichi; Ohtsuki, Mamitaro; Spelman, Lynda; Passeron, Thierry; Papp, Kim A; Kisa, Renata M; Vaile, John; Berger, Victoria; Vritzali, Eleni; Hoyt, Kim; Colombo, Matthew J; Scotto, Julie; Banerjee, Subhashis; Strober, Bruce; Thaçi, Diamant; Blauvelt, Andrew
银屑病
发表日期：2025
文献求助 收藏

Roflumilast Foam, 0.3%, for Psoriasis of the Scalp and Body: The ARRECTOR Phase 3 Randomized Clinical Trial

罗氟司特泡沫剂（0.3%）用于治疗头皮和身体银屑病：ARRECTOR III期随机临床试验

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2025.1136
Gooderham, Melinda J; Alonso-Llamazares, Javier; Bagel, Jerry; Bhatia, Neal; Bukhalo, Michael; DuBois, Janet; Ferris, Laura K; Green, Lawrence; Kircik, Leon H; Lockshin, Benjamin; Loo, Wei Jing; Papp, Kim A; Soung, Jennifer; Seal, Melissa S; Snyder, Scott; Kato, Saori; Krupa, David; Burnett, Patrick; Berk, David R; Chu, David H
银屑病
发表日期：2025
文献求助 收藏

Ixekizumab and Malignant Neoplasms: A Pooled Analysis of Data From 25 Randomized Clinical Trials

伊克珠单抗与恶性肿瘤：25项随机临床试验数据的汇总分析

期刊:Jama Dermatology
影响因子:11
doi:10.1001/jamadermatol.2025.2056
Merola, Joseph F; Papp, Kim A; Deodhar, Atul; Blauvelt, Andrew; Kronbergs, Andris; Feely McDonald, Meghan; Eberhart, Nadezdha; Zhu, Danting; Inman, Elsa; Grace, Elsie; Holzkaemper, Thorsten; Rahman, Proton; Marzo-Ortega, Helena; Gottlieb, Alice B; Schwartzman, Sergio; Lebwohl, Mark
肿瘤
肿瘤免疫
发表日期：2025
文献求助 收藏

Ruxolitinib Cream Monotherapy Improved Symptoms and Quality of Life in Adults and Adolescents with Mild-to-Moderate Atopic Dermatitis: Patient-Reported Outcomes from Two Phase III Studies

鲁索替尼乳膏单药治疗改善了轻度至中度特应性皮炎成人和青少年患者的症状和生活质量：两项 III 期研究的患者报告结果

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-024-00901-z
Simpson, Eric L; Augustin, Matthias; Thaçi, Diamant; Misery, Laurent; Armstrong, April W; Blauvelt, Andrew; Papp, Kim A; Szepietowski, Jacek C; Boguniewicz, Mark; Kwatra, Shawn G; Kallender, Howard; Sturm, Daniel; Ren, Haobo; Kircik, Leon
发表日期：2025
文献求助 收藏

Long-Term Safety and Efficacy of Risankizumab to Treat Moderate-to-Severe Plaque Psoriasis: Final LIMMitless Phase 3, Open-Label Extension Trial Results

Risankizumab治疗中重度斑块状银屑病的长期安全性和有效性：LIMMitless III期开放标签扩展试验的最终结果

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00964-6
Papp, Kim A; Lebwohl, Mark G; Puig, Lluís; Ohtsuki, Mamitaro; Beissert, Stefan; Gooderham, Melinda; Amin, Ahmad Z; Wu, Tianshuang; Rubant, Simone; Bialik, Brenton; Ashley, Doug; Soliman, Ahmed M; Chen, Michael M; Blauvelt, Andrew
银屑病
多发性骨髓瘤
发表日期：2025
文献求助 收藏

Efficacy and Safety of Upadacitinib in Patients With Moderate-to-Severe Atopic Dermatitis: Phase 3 Randomized Clinical Trial Results Through 140 Weeks

Upadacitinib治疗中重度特应性皮炎患者的疗效和安全性：3期随机临床试验140周结果

期刊:American Journal of Clinical Dermatology
影响因子:8.8
doi:10.1007/s40257-025-00975-3
Irvine, Alan D; Prajapati, Vimal H; Guttman-Yassky, Emma; Simpson, Eric L; Papp, Kim A; Blauvelt, Andrew; Chu, Chia-Yu; Hong, H Chih-Ho; Gold, Linda F Stein; de Bruin-Weller, Marjolein; Bieber, Thomas; Kabashima, Kenji; Rosmarin, David; Sancho, Cristina; Calimlim, Brian M; Grada, Ayman; Yang, Yang; Wu, Xiaoqiang; Levy, Gweneth; Raymundo, Eliza M; Teixeira, Henrique D; Silverberg, Jonathan I
发表日期：2025
文献求助 收藏